Retatrutide + Cagrilintide Blend

Retatrutide + Cagrilintide (15mg Blend) — Incretin & Amylin Research Compound

This dual peptide blend pairs Retatrutide, a triple receptor agonist (GLP-1, GIP and glucagon), with Cagrilintide, a long-acting amylin analog, in a single lyophilised vial containing 12.5mg Retatrutide and 2.5mg Cagrilintide (15mg total). Omega Peptides Australia supplies it as a high-purity (≥99% HPLC) COA-verified powder, dispatched same day from within Australia.

Often searched as the reta cagri blend or CagriReta, this compound gives researchers looking to buy Retatrutide and Cagrilintide in Australia verified purity, transparent batch documentation and reliable domestic supply.

Key research areas

• Incretin signalling — Retatrutide studied as a triple agonist across the GLP-1, GIP and glucagon receptors
• Amylin pathway — Cagrilintide studied as a long-acting amylin analog acting on a separate, complementary pathway
• Metabolic & energy-balance research — studied across metabolic and body-composition models
• Appetite & satiety signalling — the two compounds studied together for their combined effect on food-intake regulation models
• Comparative agonist research — studied alongside single-agonist and dual-agonist compounds

Specifications

Quality and COA verification

Every batch is independently tested by Janoshik Laboratories and supported by a Certificate of Analysis confirming identity and purity above 99%. The lyophilised format supports stability in storage and transit, and orders are packaged securely for reliable shipping across Australia with AusPost tracking.

Related research products

• Retatrutide — as a standalone triple agonist
• Cagrilintide 10mg — as a standalone amylin analog
• Bacteriostatic Water 10mL — for reconstitution
• Tirzepatide — for comparative agonist research

Frequently asked questions

What is the Retatrutide + Cagrilintide blend?
A dual research blend pairing Retatrutide, a triple receptor agonist (GLP-1, GIP and glucagon), with Cagrilintide, a long-acting amylin analog, supplied as a high-purity COA-verified lyophilised powder for laboratory research.

What is in each vial?
A total of 15mg: 12.5mg Retatrutide and 2.5mg Cagrilintide.

How does the blend work?
The two peptides act on complementary pathways, Retatrutide across the incretin receptors (GLP-1, GIP and glucagon) and Cagrilintide on the amylin pathway, studied together for their combined effect in metabolic and appetite-regulation research models.

Why combine Retatrutide and Cagrilintide?
Because they target separate mechanisms, researchers study the two together to model additive or complementary effects that a single compound does not cover on its own.

How do you reconstitute it?
Reconstitute with bacteriostatic water immediately before use. Add the water slowly down the inside wall of the vial and swirl gently, do not shake. Store the reconstituted solution at 2–8°C and use within 28 days.

How should it be stored?
Store the lyophilised vial at 2–8°C away from light and moisture, and avoid repeated freeze-thaw cycles. After reconstitution, keep refrigerated at 2–8°C and use within 28 days.

Is every batch COA verified?
Yes. Each batch is independently tested by Janoshik with a Certificate of Analysis confirming identity and purity above 99%.

Where can I buy the Retatrutide + Cagrilintide blend in Australia?
Directly from Omega Peptides Australia, dispatched domestically with same-day dispatch on orders before 12pm AEST and batch CoAs available in our library.

Is it legal in Australia?
Omega Peptides Australia supplies this blend strictly for lawful in-vitro laboratory research. It is not approved by the TGA for human or veterinary use and is not sold as a medicine or supplement. Purchasers are responsible for ensuring their intended use complies with all applicable laws.

⚠ For in-vitro research and laboratory use only. Not for human or veterinary use.